Plus Therapeutics Balance Sheet (2010-2025) | PSTV

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	14.45M	17.16M	21.28M		21.24M	18.09M	20.27M	18.12M	12.72M	10.89M	11.01M	8.55M	0.07M	4.91M	1.22M	0.08M	9.87M	2.23M	13.29M	13.10M
Short-term Investments (Quarter)													0.32M	3.52M	3.56M	3.53M		4.65M	3.31M	4.36M
Cash & Current Investments (Quarter)	14.45M	17.16M	21.28M		21.24M	18.09M	20.27M	18.12M	12.72M	10.89M	11.01M	8.55M	0.40M	8.44M	4.79M	3.61M	9.87M	6.88M	16.60M	17.46M
Receivables - Net (Quarter)																0.60M		1.00M		0.30M
Receivables - Other (Quarter)							0.07M			0.72M	0.09M					0.57M		1.02M		0.32M
Receivables (Quarter)																1.17M		2.02M		0.62M
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)
Prepaid Assets (Quarter)	1.00M	0.84M	0.82M	1.32M	0.86M	0.80M	0.54M	3.00M	0.91M	0.75M	0.49M	0.41M	0.99M	0.94M	0.58M	0.56M	0.41M	1.31M	0.98M	1.73M
Current Assets (Quarter)	15.45M	18.00M	22.10M	19.72M	22.10M	18.89M	20.88M	21.82M	13.63M	12.36M	11.58M	9.83M	4.21M	9.38M	5.36M	5.26M	10.87M	9.21M	17.59M	15.17M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.82M	1.74M	1.65M	1.48M	1.56M	1.56M	1.45M	1.32M	1.28M	1.14M	1.01M	0.91M	0.80M	0.73M	0.59M	0.45M	0.32M	0.29M	0.27M	0.26M
Long-Term Investments (Quarter)													0.77M			3.50M		4.60M
Goodwill (Quarter)	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M
Intangibles (Quarter)	0.08M	0.07M	0.06M	0.05M	0.15M	0.13M	0.11M	0.09M	0.08M	0.06M	0.05M	0.04M	0.03M	0.56M	0.51M	0.47M	0.43M	0.40M	0.37M	0.33M
Goodwill & Intangibles (Quarter)	0.45M	0.44M	0.43M	0.42M	0.52M	0.50M	0.48M	0.47M	0.45M	0.44M	0.42M	0.41M	0.41M	0.93M	0.89M	0.84M	0.81M	0.77M	0.75M	0.70M
Other Non-Current Assets (Quarter)	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M	0.01M	0.03M	0.03M	0.03M	0.03M	0.03M	0.01M	0.02M	0.04M	0.04M	0.12M
Non-Current Assets (Quarter)	2.89M	2.83M	2.65M	2.26M	2.41M	2.38M	2.23M	2.05M	2.01M	1.83M	1.69M	1.55M	1.41M	1.83M	1.61M	1.37M	1.19M	1.14M	1.08M	1.16M
Assets (Quarter)	18.34M	20.83M	24.75M	21.98M	24.52M	21.27M	23.10M	23.87M	15.64M	14.20M	13.28M	11.39M	5.62M	11.21M	6.98M	6.63M	12.06M	10.35M	18.67M	16.32M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	1.72M	1.61M	2.63M	4.15M	3.20M	5.26M	5.71M	8.36M	6.50M	6.58M	6.07M	4.76M	6.45M	6.95M	7.91M	11.29M	9.22M	6.36M	11.62M	5.92M
Payables (Quarter)	1.72M	1.61M	2.63M	4.15M	3.20M	5.26M	5.71M	8.36M	6.50M	6.58M	6.07M	4.76M	6.45M	6.95M	7.91M	11.29M	9.22M	6.36M	11.62M	5.92M
Accumulated Expenses (Quarter)				0.78M				0.99M				0.99M				0.92M				0.99M
Other Accumulated Expenses (Quarter)				0.12M																0.94M
Short term Debt (Quarter)	6.49M	6.62M	6.75M	1.61M	1.61M	1.61M	1.61M	1.61M	5.06M	4.71M	4.35M	3.98M	3.59M	3.29M	3.29M	3.29M				0.75M
Current Leases (Quarter)	0.11M	0.13M	0.11M	0.11M	0.11M	0.10M	0.11M	0.11M	0.11M	0.11M	0.12M	0.12M	0.12M	0.09M	0.07M	0.04M	0.04M	0.03M	0.02M	0.06M
Current Deferred Revenue (Quarter)									1.14M				0.25M	2.30M	0.84M	0.93M	1.30M	0.93M	1.97M	0.93M
Total Current Liabilities (Quarter)	8.31M	8.35M	9.49M	5.87M	4.92M	6.97M	7.42M	11.85M	12.80M	11.40M	10.54M	10.73M	10.40M	18.79M	12.11M	15.55M	10.56M	7.32M	13.62M	12.31M
Non-Current Liabilities
Non-Current Debt (Quarter)				5.00M	4.72M	4.42M	4.11M	3.79M
Non-Current Deffered Revenue (Quarter)								1.64M				1.92M
Liabilities from Discontinued Operations (Quarter)
Operating Leases (Quarter)	0.50M	0.53M	0.50M	0.27M	0.23M	0.20M	0.17M	0.14M	0.08M	0.14M	0.12M	0.09M	0.06M	0.05M	0.04M	0.03M				0.01M
Other Non-Current Liabilities (Quarter)	0.01M	0.01M	0.00M	0.00M													25.14M
Total Non-Current Liabilities (Quarter)	8.82M	8.88M	9.99M	11.14M													10.56M	7.32M
Total Liabilities (Quarter)	8.82M	8.89M	9.99M	11.14M	9.87M	11.59M	11.70M	17.42M	12.96M	11.54M	10.66M	12.74M	10.46M	18.84M	12.15M	15.58M	35.70M	7.32M	13.62M	12.33M
Shareholder's Equity
Total Debt (Quarter)	6.49M	6.62M	6.75M	6.61M	6.33M	6.03M	5.72M	5.39M	5.06M	4.71M	4.35M	3.98M	3.59M	3.29M	3.29M	3.29M				0.75M
Common Equity (Quarter)	9.51M	11.95M	14.76M	10.84M	14.64M	9.68M	11.40M	6.45M	2.68M	2.66M	2.62M	-1.35M	-4.84M	-7.62M	-5.17M	-8.95M	-23.64M	3.03M	5.05M	4.00M
Shareholder's Equity (Quarter)	9.51M	11.95M	14.76M	10.84M	14.64M	9.68M	11.40M	6.45M	2.68M	2.66M	2.62M	-1.35M	-4.84M	-7.62M	-5.17M	-8.95M	-23.64M	3.03M	5.05M	4.00M
Liabilities and Shareholders Equity (Quarter)	18.34M	20.83M	24.75M	21.98M	24.52M	21.27M	23.10M	23.87M	15.64M	14.20M	13.28M	11.39M	5.62M	11.21M	6.98M	6.63M	12.06M	10.35M	18.67M	16.32M
Treasury Shares (Quarter)												-0.08M	-0.26M	-0.26M	-0.26M	0.26M	-0.26M	-0.26M	2.82M	2.64M
Retained Earnings (Quarter)	-436.23M	-439.00M	-442.80M	-446.91M	-451.03M	-456.31M	-461.53M	-467.19M	-472.00M	-473.50M	-476.69M	-480.50M	-483.76M	-486.70M	-489.60M	-493.48M	-510.90M	-505.70M	-510.20M	-515.87M

Research Tools

Plus Therapeutics Balance Sheet (2010-2025) | PSTV

Create an account

Sign In

Reset Password